Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan R Targan

Showing results (31-40 of 189) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestineOffer Cohavy, Jaclyn Zhou, Steve W Granger, et al.
Inflammatory Bowel Diseases|October 1, 2008
Enhanced CBir1-specific innate and adaptive immune responses in Crohn's diseaseChong Shen, Carol J Landers, Carrie Derkowski, et al.
Annals of the New York Academy of Sciences|October 24, 2006
Molecular approaches to the role of the microbiota in inflammatory bowel diseaseCharles O Elson, Yingzi Cong, Fengxia Qi, et al.
International Journal of Molecular Sciences|January 5, 2021
Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal OrganoidsMichael J Workman, Elissa Troisi, Stephan R Targan, et al.
Inflammatory Bowel Diseases|August 1, 2007
TNFSF15 is an ethnic-specific IBD geneYoana Picornell, Ling Mei, Kent Taylor, et al.
Inflammatory Bowel Diseases|August 30, 2014
IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretionRivkah Gonsky, Richard L Deem, Carol J Landers, et al.
Inflammatory Bowel Diseases|October 29, 2005
State of the art: IBD therapy and clinical trials in IBDKim L Isaacs, James D Lewis, William J Sandborn, et al.
The American Journal of Gastroenterology|February 26, 2009
Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's diseaseDaniel C Baumgart, James N Lowder, Stephan R Targan, et al.
The American Journal of Gastroenterology|June 18, 2003
Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprineMarla C Dubinsky, Edward J Feldman, Maria T Abreu, et al.
Inflammatory Bowel Diseases|December 17, 2021
Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem CellsHannah Q Estrada, Shachi Patel, Shervin Rabizadeh, et al.
Pageof 19

Showing results (31-40 of 189) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestineOffer Cohavy, Jaclyn Zhou, Steve W Granger, et al.
Inflammatory Bowel Diseases|October 1, 2008
Enhanced CBir1-specific innate and adaptive immune responses in Crohn's diseaseChong Shen, Carol J Landers, Carrie Derkowski, et al.
Annals of the New York Academy of Sciences|October 24, 2006
Molecular approaches to the role of the microbiota in inflammatory bowel diseaseCharles O Elson, Yingzi Cong, Fengxia Qi, et al.
International Journal of Molecular Sciences|January 5, 2021
Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal OrganoidsMichael J Workman, Elissa Troisi, Stephan R Targan, et al.
Inflammatory Bowel Diseases|August 1, 2007
TNFSF15 is an ethnic-specific IBD geneYoana Picornell, Ling Mei, Kent Taylor, et al.
Inflammatory Bowel Diseases|August 30, 2014
IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretionRivkah Gonsky, Richard L Deem, Carol J Landers, et al.
Inflammatory Bowel Diseases|October 29, 2005
State of the art: IBD therapy and clinical trials in IBDKim L Isaacs, James D Lewis, William J Sandborn, et al.
The American Journal of Gastroenterology|February 26, 2009
Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's diseaseDaniel C Baumgart, James N Lowder, Stephan R Targan, et al.
The American Journal of Gastroenterology|June 18, 2003
Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprineMarla C Dubinsky, Edward J Feldman, Maria T Abreu, et al.
Inflammatory Bowel Diseases|December 17, 2021
Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem CellsHannah Q Estrada, Shachi Patel, Shervin Rabizadeh, et al.
Pageof 19